Table 1.
Unadjusted prevalence ratios (PRs) of microscopic inflammatory signs by sociodemographic, biological and behavioral characteristics, and clinical conditions.
| Characteristics | n | Total n | Prev % | PMNLs>5 (Urethral smear) PR (95% CI) | p | PMNLs>10 (Urethral smear) PR (95% CI) | p | PMNLs > epit. (Vag. wet mount) PR (95% CI) | p | PMNLs>30 (cervical smear) PR (95% CI) | p |
|---|---|---|---|---|---|---|---|---|---|---|---|
| No regular partner | 236 | 375 | 63% | 0.89 (0.72-1.11) | 0.302 | 0.86 (0.56-1.33) | 0.502 | 0.93 (0.63-1.36) | 0.695 | 0.63 (0.47-0.84) | 0.002 |
| Regular or cohabitant partner last 6 |
139 | 375 | 37% | 1.11 (0.89-1.38) | 0.336 | 1.16 (0.75 - 1.79) | 0.502 | 1.09 (0.74-1.59) | 0.667 | 1.59 (1.19-2.11) | 0.001 |
| Partner>1 last 6 months | 277 | 367 | 75% | 1.26 (0.94-1.67) | 0.109 | 0.96 (0.58 - 1.57) | 0.858 | 1.08 (0.69-1.70) | 0.733 | 1.23 (0.85-1.78) | 0.265 |
| Condom use vaginal sex | 122 | 358 | 34% | 0.82 (0.64-1.04) | 0.115 | 0.77 (0.47 - 1.24) | 0.280 | 0.58 (0.36-0.92) | 0.021 | 0.78 (0.56-1.10) | 0.170 |
| Condom use last time | 45 | 363 | 12% | 1.06 (0.77-1.46) | 0.701 | 0.99 (0.51 - 1.94) | 0.981 | 0.95 (0.53-1.70) | 0.867 | 1.01 (0.65-1.58) | 0.932 |
| Symptoms of vaginal discharge | 190 | 375 | 50% | 0.81 (0.65-1.00) | 0.059 | 0.79 (0.52 - 1.22) | 0.293 | 1.56 (1.06-2.29) | 0.024 | 1.07 (0.80-1.43) | 0.630 |
| Dysuria | 75 | 375 | 20% | 1.29 (1.02-1.63) | 0.030 | 2.00 (1.30 - 3.08) | 0.002 | 0.98 (0.62-1.57) | 0.944 | 1.13 (0.80-1.60) | 0.465 |
| Warts | 38 | 375 | 10% | 1.07 (0.76-1.50) | 0.681 | 0.13 (0.02 - 0.91) | 0.040 | 0.55 (0.24-1.26) | 0.158 | 1.24 (0.81-1.89) | 0.313 |
| Cervical motion tenderness | 11 | 375 | 3% | 1.99 (1.60-2.47) | <0.001 | 2.04 (0.90 - 4.59) | 0.086 | 3.74 (2.59-5.4) | <0.001 | 1.71 (0.97-2.99) | 0.060 |
| Mucopurulent endocervical exudate | 36 | 375 | 10% | 1.34 (1.01-1.78) | 0.041 | 1.98 (1.18 - 3.33) | 0.010 | 3.34 (2.38-4.69) | <0.001 | 2.42 (1.84-3.19) | <0.001 |
| Endocervical bleeding easily induced | 73 | 375 | 19% | 1.25 (0.99-1.59) | 0.060 | 1.15 (0.69 - 1.92) | 0.594 | 2.46 (1.72-3.51) | <0.001 | 1.53 (1.12-2.08) | 0.006 |
| Cervical edema | 22 | 375 | 6% | 1.17 (0.78-1.74) | 0.428 | 1.25 (0.56 - 2.8) | 0.581 | 3.67 (2.63-5.11) | <0.001 | 2.08 (1.46-2.95) | <0.001 |
| Without clinical finding for cervicitis | 121 | 375 | 32% | 0.80 (0.63-1.03) | 0.096 | 0.86 (0.53 - 1.38) | 0.522 | 0.32 (0.18-0.58) | <0.001 | 0.81 (0.58-1.12) | 0.215 |
| Chlamydia trachomatis∗ | 39 | 375 | 10% | 1.84 (1.50-2.25) | <0.001 | 3.27 (2.17 - 4.94) | <0.0001 | 1.82 (1.16-2.85) | 0.009 | 2.00 (1.46-2.72) | <0.001 |
| Mycoplasma genitalium∗ | 16 | 372 | 4% | 1.07 (0.65-1.78) | 0.767 | 1.39 (0.58 - 3.34) | 0.461 | 1.37 (0.65-2.91) | 0.411 | 1.57 (0.94-2.63) | 0.082 |
| Mycoplasma hominis∗ | 90 | 375 | 24% | 1.02 (0.79-1.31) | 0.853 | 1.29 (0.81 - 2.05) | 0.277 | 1.04 (0.67-1.60) | 0.872 | 0.90 (0.63-1.28) | 0.561 |
| Ureaplasma urealyticum∗ | 91 | 375 | 24% | 1.04 (0.82-1.33) | 0.753 | 1.19 (0.74 - 1.90) | 0.479 | 1.37 (0.92-2.04) | 0.118 | 1.35 (1.00-1.84) | 0.049 |
| Ureaplasma parvum∗ | 299 | 375 | 80% | 1.34 (0.97-1.84) | 0.066 | 1.50 (0.81 - 2.79) | 0.201 | 1.31 (0.78-2.19) | 0.303 | 0.85 (0.60-1.19) | 0.358 |
| Vaginal candidiasis∗∗ | 69 | 371 | 19% | 1.10 (0.84-1.43) | 0.468 | 1.66 (1.05 - 2.63) | 0.030 | 1.95 (1.34-2.85) | 0.001 | 1.21 (0.85-1.71) | 0.280 |
| pH>4.5 | 148 | 370 | 40% | 1.00 (0.81-1.25) | 0.932 | 0.96 (0.62 - 1.49) | 0.870 | 1.39 (0.96-2.01) | 0.085 | 1.25 (0.93-1.67) | 0.133 |
| Whiff pos Amine test | 105 | 365 | 29% | 1.03 (0.81-1.31) | 0.773 | 1.18 (0.75 - 1.87) | 0.466 | 1.37 (0.93-2.01) | 0.113 | 1.04 (0.75-1.44) | 0.793 |
| Double infection CT/MG/UU∗ | 20 | 375 | 5% | 1.42 (1.01-.00) | 0.046 | 2.33 (1.3 - 4.17) | 0.005 | 1.82 (1.03-3.22) | 0.041 | 1.75 (1.14-2.69) | <0.001 |
| Previous STD | 174 | 336 | 52% | 0.83 (0.66-1.04) | 0.110 | 1.16 (0.74 - 1.82) | 0.507 | 0.99 (0.67-1.47) | 0.947 | 1.16 (0.85-1.60) | 0.336 |
PMNL: polymorphonuclear leukocyte, ∗Positive NAAT, and ∗∗pseudohyphae in vaginal KOH wet mount.
Significant values in bold.